|
⚲
|
| N-Viro International Corp | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0000904896 |
| Sale | 2009-05-26 ($1.0 M Offered, $0.1 M Sold) |
| Fund | |
| Phone | 4195356374 |
| Address | 3450 W Central Ave Toledo, 43606 |
| Source | [EDGAR] |
| Fund AUM and Sold ($k) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2026 |
|---|---|
| Robert Bohmer | |
| Timothy Kasmoch | |
| James McHugh | |
| Mark Hagans | |
| James Hartung | |
| Thomas Kovacik | |
| Joseph Scheib | |
| Carl Richard |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
eWRLD Corp.
✚
|
0.0 | |
|
EX-0604 Fund I, a series of HyperGuap, LP
✚
|
0.0 | |
|
EX-0926 Fund I, a series of HENRY Collective Ventures, LP
✚
|
0.0 | |
|
Exa Biosciences, Inc.
✚
|
0.0 | |
|
Examen, Inc. /DE
✚
|
0.0 | |
|
Excela Capital US Fund LP
✚
|
0.0 | |
|
ExcelFin Acquisition Corp.
✚
|
0.0 | |
|
Exchange Place: All Cap II LP
✚
|
0.0 | |
|
ExchangeRight Fee Participation LLC
✚
|
0.0 | |
|
EVP Sama Investor LLC
✚
|
0.0 |